"
Meta-Analysis of the Efficacy and Adverse Reactions of Ibrutinib in the Treatment of Refractory/Relapsed Mantle Cell Lymphoma"
written by Mei Cao, Yansong Tu, Xiaoyan Jiang, Xuekun Wang, Yazhi Yang, Xiaoyan Zhang, Huaijun Tu, Jian Li,
published by
Open Journal of Preventive Medicine,
Vol.11 No.9, 2021
has been cited by the following article(s):